Cipla Limited (CIPLA)
Price | 1,185.90 -20.50 (-1.70%) | 52 Week High | 1,277.90 |
---|---|---|---|
ISIN | INE059A01026 | 52 Week Low | 852.00 |
Industry | Pharmaceuticals: Other | Volume | 2.8 M |
Sector | Health Technology | P/E Ratio TTM | 30.77 |
Market Cap | 974.5 B | 1 Year Beta | 0.06 |

Cipla Limited (CIPLA) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was founded in 1935 by Khwaja Abdul Hamied. CIPLA is one of the largest pharmaceutical companies in India and has a global presence, with operations in over 150 countries.
The company’s products include generic drugs, branded drugs, and over-the-counter (OTC) products. CIPLA’s generic drugs are available in a wide range of therapeutic categories, including anti-infectives, cardiovascular, respiratory, and anti-diabetics. The company’s branded drugs include products such as Cipramil (an antidepressant), Dolo 650 (a pain reliever), and Liv 52 (a liver tonic). CIPLA’s OTC products include products such as Vicks Vaporub (a cough suppressant) and Eno (an antacid).
CIPLA is a research-driven company and has a strong focus on innovation. The company has a number of research and development (R&D) facilities in India and abroad. CIPLA’s R&D efforts have resulted in the development of a number of new drugs, including the anti-cancer drug Infatinib.
CIPLA is committed to providing affordable healthcare to people around the world. The company has a number of programs in place to make its products accessible to people in low-income countries. CIPLA is also a member of the Access to Medicines Index, which is a global ranking of pharmaceutical companies based on their commitment to providing access to affordable medicines.
Here are some of the key facts about Cipla Limited:
- Founded in 1935
- Headquarters: Mumbai, India
- Products: generic drugs, branded drugs, and OTC products
- Revenue (FY 2022-23): ₹22,753 crores
- Employees: 17,000
- Market capitalization: ₹1.4 trillion
Cipla Limited (CIPLA) Chart
Technical Analysis of Cipla Limited (CIPLA)
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA 5 | 1,221.61 | 1,213.85 |
MA 10 | 1,230.21 | 1,224.41 |
MA 20 | 1,234.66 | 1,226.40 |
MA 30 | 1,235.49 | 1,216.07 |
MA 50 | 1,189.92 | 1,184.05 |
MA 100 | 1,080.37 | 1,120.54 |
MA 200 | 1,036.27 | 1,069.18 |
Moving Average Rating
Technical Indicators
Name | Value | Name | Value |
---|---|---|---|
Aroon Up (14) | 0.00 | Aroon Down (14) | 100.00 |
MACD Level (12, 26) | 5.14 | MACD Signal (12, 26) | 14.54 |
Relative Strength Index (7) | 20.20 | Relative Strength Index (14) | 37.61 |
Stochastic %D (14 3 3) | 26.24 | Stochastic %K (14 3 3) | 19.14 |
Stochastic RSI Fast (3, 3, 14, 14) | 7.78 | Stochastic RSI Slow (3, 3, 14, 14) | 15.22 |
Bollinger Upper Band (20) | 1,268.24 | Bollinger Lower Band (20) | 1,201.07 |
Keltner Channels Upper Band (20) | 1,277.91 | Keltner Channels Lower Band (20) | 1,174.88 |
Donchian Channels Upper Band (20) | 1,268.90 | Donchian Channels Lower Band (20) | 1,168.55 |
Ichimoku Conversion Line (9, 26, 52, 26) | 1,214.23 | Ichimoku Base Line (9, 26, 52, 26) | 1,218.73 |
Ichimoku Leading Span A (9, 26, 52, 26) | 1,186.21 | Ichimoku Leading Span B (9, 26, 52, 26) | 1,116.53 |
Positive Directional Indicator (14) | 17.73 | Negative Directional Indicator (14) | 25.88 |
Volume Weighted Average Price | 1,187.85 | Volume Weighted Moving Average 20 | 1,234.12 |
Oscillator Rating
Oscillators
Awesome Oscillator | -10.54 |
---|---|
Ultimate Oscillator (7,14,28) | 29.92 |
Money Flow (14) | 44.68 |
Chaikin Money Flow (20) | -0.25 |
Commodity Channel Index (20) | -278.60 |
Bull Bear Power | -76.12 |
High / Low
1 Month | 1,268.90 | 1,168.55 |
---|---|---|
3 Month | 1,277.90 | 989.35 |
6 Month | 1,277.90 | 876.05 |
52 Week | 1,277.90 | 852.00 |
All Time | 1,277.90 | 22.96 |
Volume
Volume | 2.8 M |
---|---|
Average 10 D | 1.7 M |
Average 30 D | 1.6 M |
Average 60 D | 1.9 M |
Average 90 D | 1.8 M |
Change/Volatility
Change | -20.50 (-1.70%) |
---|---|
Change 1W | -49.60 (-4.01%) |
Change 1M | -71.70 (-5.70%) |
Volatility | 3.47 |
Volatility W | 2.29 |
Performance
Yesterday | 9.78 |
---|---|
Weekly | -3.96 |
Monthly | -5.28 |
3 Month | 18.60 |
6 Month | 36.45 |
Yearly | 11.76 |
5 Year | 79.14 |
All Time | 5,026.37 |
Misc.
Average Day Range (14) | 23.71 |
---|---|
Average Directional Index (14) | 41.43 |
Average True Range (14) | 25.81 |
Williams Percent Range (14) | -82.38 |
Rate Of Change (9) | -4.72 |
Hull Moving Average (9) | 1,210.93 |
Momentum (10) | -63.40 |
Parabolic SAR | 1,262.10 |
PIVOT POINTS of Cipla Limited (CIPLA)
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Classic | 972.70 | 1,100.60 | 1,179.10 | 1,228.50 | 1,307.00 | 1,356.40 | 1,484.30 |
Fibonacci | 1,100.60 | 1,149.46 | 1,179.64 | 1,228.50 | 1,277.36 | 1,307.54 | 1,356.40 |
Camarilla | 1,222.43 | 1,234.15 | 1,245.88 | 1,228.50 | 1,269.32 | 1,281.05 | 1,292.77 |
Woodie's | 1,073.05 | 1,111.53 | 1,200.95 | 1,239.43 | 1,328.85 | 1,367.33 | 1,456.75 |
DeMark's | - | - | 1,203.80 | 1,240.85 | 1,331.70 | - | - |
Financial Analysis of Cipla Limited (CIPLA)
Income Statement
Basic EPS (FY) | 34.72 |
---|---|
Basic EPS (TTM) | 38.55 |
EBITDA (Annual YoY Growth) | 10.27 |
EBITDA (Quarterly QoQ Growth) | 27.28 |
EBITDA (Quarterly YoY Growth) | 30.66 |
EBITDA (TTM) | 53.8 B |
EBITDA (TTM YoY Growth) | 23.61 |
EPS Diluted (Annual YoY Growth) | 11.30 |
EPS Diluted (FY) | 34.69 |
EPS Diluted (MRQ) | 12.33 |
EPS Diluted (Quarterly QoQ Growth) | 89.33 |
EPS Diluted (Quarterly YoY Growth) | 45.06 |
EPS Diluted (TTM) | 38.54 |
EPS Diluted (TTM YoY Growth) | 25.12 |
EPS Forecast (MRQ) | 12.24 |
Free Cash Flow (Annual YoY Growth) | -11.15 |
Free Cash Flow Margin (FY) | 10.77 |
Gross Profit (Annual YoY Growth) | 11.85 |
Gross Profit (FY) | 80.5 B |
Gross Profit (MRQ) | 27.9 B |
Gross Profit (Quarterly QoQ Growth) | 17.82 |
Gross Profit (Quarterly YoY Growth) | 30.16 |
Gross Profit (TTM YoY Growth) | 18.79 |
Last Year Revenue (FY) | 227 B |
Revenue (Annual YoY Growth) | 4.51 |
Revenue per Employee (FY) | 5.8 M |
Revenue (Quarterly QoQ Growth) | 10.27 |
Revenue (Quarterly YoY Growth) | 17.74 |
Revenue (TTM YoY Growth) | 9.58 |
Net Income (Annual YoY Growth) | 11.33 |
Net Income (FY) | 28 B |
Net Income (Quarterly QoQ Growth) | 89.42 |
Net Income (Quarterly YoY Growth) | 45.06 |
Net Income (TTM YoY Growth) | 25.03 |
Total Revenue (FY) | 227 B |
Valuation
Enterprise Value/EBITDA (TTM) | 18.12 |
---|---|
Number of Employees | 38,955.00 |
Number of Shareholders | 485.5 T |
Shares Float | 498.3 M |
Price to Book (FY) | 4.09 |
Price to Earnings Ratio (TTM) | 30.77 |
Price to Revenue Ratio (TTM) | 4.04 |
Price to Sales (FY) | 4.22 |
Total Shares Outstanding | 807.3 M |
Research & development Ratio (FY) | 1.70 |
Research & development Ratio (TTM) | 5.98 |
Selling & Admin expenses Ratio (FY) | 15.40 |
Selling & Admin expenses Ratio (TTM) | 19.01 |
Balance Sheet
Total Assets (Annual YoY Growth) | 8.72 |
---|---|
Total Debt (Annual YoY Growth) | -23.93 |
Total Liabilities (FY) | 57.5 B |
Cash & Equivalents (FY) | 6.4 B |
Cash and short term investments (FY) | 62.8 B |
Operating Metrics
Dividends
Dividend Yield Forward | 0.70 |
---|---|
Dividends Paid (FY) | -4,035,000,000.00 |
Dividends per share (Annual YoY Growth) | 70.00 |
Dividends per Share (FY) | 8.50 |
Margins
Net Margin (FY) | 12.34 |
---|---|
Net Margin (TTM) | 13.12 |
Gross Margin (FY) | 35.44 |
Gross Margin (TTM) | 42.79 |
Operating Margin (FY) | 17.88 |
Operating Margin (TTM) | 17.80 |
Pretax Margin (TTM) | 18.72 |
Cipla Limited (CIPLA) FUTURES
Expiry | Open | High | Low | Close | Settle | Contracts | Value | OI | OI Change |
---|---|---|---|---|---|---|---|---|---|
28-Sep-23 | 1,208.35 | 1,209.95 | 1,169.00 | 1,189.20 | 1,189.20 | 4.9 T | 37.4 T | 10.4 M | -258,700 |
26-Oct-23 | 1,215.05 | 1,215.05 | 1,176.25 | 1,196.80 | 1,196.80 | 2.1 T | 16.3 T | 788.5 T | 406.9 T |
30-Nov-23 | 1,211.15 | 1,211.15 | 1,185.00 | 1,204.05 | 1,204.05 | 26 | 202 | 22.1 T | 3.9 T |
Cipla Limited (CIPLA) OPTIONS
Related Companies (Peers) to Cipla Limited (CIPLA)
Price | 635.95 2.00 (0.32%) | 52 Week High | 775.45 |
---|---|---|---|
ISIN | INE098F01031 | 52 Week Low | 554.05 |
Industry | Pharmaceuticals: Other | Volume | 32,284 |
Sector | Health Technology | P/E Ratio TTM | 43.12 |
Market Cap | 18.5 B | 1 Year Beta | 0.88 |

Price | 866.40 -10.05 (-1.15%) | 52 Week High | 907.70 |
---|---|---|---|
ISIN | INE406A01037 | 52 Week Low | 397.20 |
Industry | Pharmaceuticals: Other | Volume | 1.4 M |
Sector | Health Technology | P/E Ratio TTM | 25.67 |
Market Cap | 513.3 B | 1 Year Beta | 0.66 |

Price | 336.80 13.60 (4.21%) | 52 Week High | 381.00 |
---|---|---|---|
ISIN | INE101D01020 | 52 Week Low | 267.75 |
Industry | Pharmaceuticals: Other | Volume | 3.8 M |
Sector | Health Technology | P/E Ratio TTM | 18.89 |
Market Cap | 78.2 B | 1 Year Beta | 0.79 |

Price | 1,097.45 -29.85 (-2.65%) | 52 Week High | 1,174.50 |
---|---|---|---|
ISIN | INE326A01037 | 52 Week Low | 628.00 |
Industry | Pharmaceuticals: Other | Volume | 1.3 M |
Sector | Health Technology | P/E Ratio TTM | 51.59 |
Market Cap | 513.9 B | 1 Year Beta | 0.46 |

Price | 113.05 2.55 (2.31%) | 52 Week High | 155.90 |
---|---|---|---|
ISIN | INE933A01014 | 52 Week Low | 88.50 |
Industry | Pharmaceuticals: Other | Volume | 91,139 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 3.7 B | 1 Year Beta | 0.96 |

Cipla Limited (CIPLA) Related Indices
News Related to Cipla Limited (CIPLA)
Sep 22, 2023, 9:04 pm
Market Summary for September 22, 2023 Indian equity markets closed in the green on September 22, 2023, supported by buying in select banking and automobile stocks. Sectors such as pharma, information technology, and metals were the major drags. Options data suggests a sideways to positive momentum in the near term.
Sep 22, 2023, 5:52 pm
Indian market drops on September 22 despite inclusion of Indian bonds in JP Morgan index Indian benchmark indices Sensex and Nifty fell for the fourth consecutive day on September 22, despite the inclusion of Indian bonds in the JP Morgan Government Bond Index-Emerging Markets (GBI-EM) global index suite from June 2024. The market is expected to remain volatile in the near term, with key support at 19,600 for Nifty.
Sep 22, 2023, 4:46 pm
Pharma Sector Sees Bearish Sentiment on September 22 The pharmaceutical sector is experiencing bearish sentiment on September 22, with profit-booking pressure and short positions in several individual stocks, including Glenmark, Cipla, Alkem, and Dr Reddy's. Analysts believe that the Nifty Pharma Index could see further weakness if it breaks below the 14700-14800 support zone. On the other hand, Aurobindo Pharma is seen as a moderately bullish stock, with strong resistance at the 900 strike price and strong support at the 850 and 860 strike prices. Traders should be cautious and monitor the market closely for any further developments.
Sep 21, 2023, 9:12 pm
Indian markets fall for third straight day on September 21 Indian stock markets fell for the third consecutive day on September 21, tracking weak global cues. The US Federal Reserve maintained the status quo in its policy meeting but indicated that interest rates will remain higher for longer. This led to selling by foreign institutional investors (FII) and elevated crude oil prices remained a concern. Broader market performed even worse than the benchmark indices. All sectoral indices, barring Nifty Media, closed in the red. Nifty PSU Bank was the biggest loser during the day, falling 2.28 percent. Analysts believe that the market may remain volatile in the near term due to factors such as the hawkish stance by the US Fed, rising oil prices and erratic rainfall. However, they advise investors to stay stock-specific with a focus on risk management.
Stock Sectors
- 52Commercial Services
- 13Communications
- 72Consumer Durables
- 111Consumer Non-Durables
- 81Consumer Services
- 33Distribution Services
- 49Electronic Technology
- 18Energy Minerals
- 245Finance
- 20Health Services
- 95Health Technology
- 85Industrial Services
- 2Miscellaneous
- 134Non-Energy Minerals
- 357Process Industries
- 270Producer Manufacturing
- 31Retail Trade
- 103Technology Services
- 41Transportation
- 38Utilities
Stock Industries
- 3Advertising/Marketing Services
- 7Aerospace & Defense
- 62Agricultural Commodities/Milling
- 14Air Freight/Couriers
- 3Airlines
- 6Alternative Power Generation
- 4Aluminum
- 39Apparel/Footwear
- 9Apparel/Footwear Retail
- 64Auto Parts: OEM
- 11Automotive Aftermarket
- 9Beverages: Alcoholic
- 1Beverages: Non-Alcoholic
- 1Biotechnology
- 12Broadcasting
- 17Building Products
- 4Cable/Satellite TV
- 1Catalog/Specialty Distribution
- 40Chemicals: Agricultural
- 18Chemicals: Major Diversified
- 75Chemicals: Specialty
- 3Coal
- 4Commercial Printing/Forms
- 1Computer Communications
- 4Computer Peripherals
- 37Construction Materials
- 3Consumer Sundries
- 25Containers/Packaging
- 2Contract Drilling
- 5Data Processing Services
- 1Department Stores
- 1Drugstore Chains
- 25Electric Utilities
- 46Electrical Products
- 3Electronic Components
- 9Electronic Equipment/Instruments
- 11Electronic Production Equipment
- 4Electronics Distributors
- 1Electronics/Appliance Stores
- 9Electronics/Appliances
- 75Engineering & Construction
- 1Environmental Services
- 55Finance/Rental/Leasing
- 28Financial Conglomerates
- 3Financial Publishing/Services
- 3Food Distributors
- 3Food Retail
- 7Food: Major Diversified
- 7Food: Meat/Fish/Dairy
- 28Food: Specialty/Candy
- 9Forest Products
- 7Gas Distributors
- 10Home Furnishings
- 1Home Improvement Chains
- 7Homebuilding
- 13Hospital/Nursing Management
- 18Hotels/Resorts/Cruise lines
- 14Household/Personal Care
- 9Industrial Conglomerates
- 51Industrial Machinery
- 35Industrial Specialties
- 54Information Technology Services
- 3Integrated Oil
- 7Internet Retail
- 11Internet Software/Services
- 43Investment Banks/Brokers
- 16Investment Managers
- 1Investment Trusts/Mutual Funds
- 6Life/Health Insurance
- 18Major Banks
- 6Major Telecommunications
- 6Marine Shipping
- 1Medical Distributors
- 2Medical Specialties
- 7Medical/Nursing Services
- 32Metal Fabrication
- 1Miscellaneous
- 39Miscellaneous Commercial Services
- 24Miscellaneous Manufacturing
- 14Motor Vehicles
- 21Movies/Entertainment
- 4Multi-Line Insurance
- 3Office Equipment/Supplies
- 1Oil & Gas Pipelines
- 1Oil & Gas Production
- 11Oil Refining/Marketing
- 6Oilfield Services/Equipment
- 7Other Consumer Services
- 20Other Consumer Specialties
- 19Other Metals/Minerals
- 10Other Transportation
- 33Packaged Software
- 3Personnel Services
- 2Pharmaceuticals: Generic
- 84Pharmaceuticals: Major
- 6Pharmaceuticals: Other
- 1Precious Metals
- 4Publishing: Books/Magazines
- 7Publishing: Newspapers
- 18Pulp & Paper
- 1Railroads
- 51Real Estate Development
- 22Regional Banks
- 8Restaurants
- 3Semiconductors
- 2Specialty Insurance
- 7Specialty Stores
- 5Specialty Telecommunications
- 64Steel
- 11Telecommunications Equipment
- 84Textiles
- 3Tobacco
- 1Tools & Hardware
- 7Trucking
- 24Trucks/Construction/Farm Machinery
- 25Wholesale Distributors
- 2Wireless Telecommunications
Leave a Reply